What does a PHQ‑9 score of 17 indicate and how should major depressive disorder be diagnosed based on this score?

PHQ-9 Score of 17: Interpretation and Diagnostic Approach

A PHQ-9 score of 17 indicates moderately severe depression and mandates immediate referral to a psychiatrist, psychologist, or equivalently trained mental health professional for comprehensive diagnostic assessment to determine if major depressive disorder is present. 1

What the Score Means

A PHQ-9 score of 17 falls within the moderately severe depression range (15-19) 1. This scoring framework is well-established:

• 1-7: None/mild symptomatology
• 8-14: Moderate symptomatology
• 15-19: Moderately severe symptomatology
• 20-27: Severe symptomatology

At this severity level, the patient has the majority of depressive symptoms, potentially including suicidal ideation, and these symptoms interfere moderately to markedly with daily functioning 1.

Critical Safety Assessment First

Before proceeding with diagnostic workup, immediately assess for risk of harm to self or others. If present, this requires:

• Emergency evaluation by a licensed mental health professional
• Facilitation of a safe environment with one-to-one observation
• Immediate harm-reduction interventions 2, 1

The presence of psychosis, severe agitation, or confusion (delirium) also warrants emergency evaluation 1.

Diagnostic Process

The PHQ-9 is NOT a Diagnostic Tool

A crucial caveat: The PHQ-9 is a screening instrument that assesses symptoms of major depressive disorder as defined by DSM-IV criteria, but it does not establish a diagnosis 2. The score indicates symptom severity and the need for further evaluation, not a confirmed diagnosis of MDD.

Required Next Steps for Diagnosis

With a score of 17, the patient requires formal diagnostic assessment by a mental health professional to:

1. Identify the nature and extent of depressive symptoms
2. Determine presence or absence of a mood disorder 2
3. Rule out medical or substance-induced causes of depressive symptoms (e.g., interferon administration, unrelieved pain, fatigue, delirium from infection or electrolyte imbalance) 2

Specific Risk Factors to Evaluate

When making the referral, document pertinent history and risk factors 1:

• Prior mood disorder (with or without prior treatment)
• Comorbid conditions: anxiety disorders (e.g., GAD), substance use
• Other chronic illnesses: coronary heart disease, COPD
• Disease-related factors: recurrent, advanced, or progressive disease
• Social factors: living alone (single, widowed, divorced), unemployment, low financial resources, lower education level

Diagnostic Accuracy Considerations

Research shows that at the commonly recommended cutoff of 10, the PHQ-9 has a sensitivity of 88% and specificity of 88% for major depression 3. However, for a score of 17, the positive predictive value is high—this patient very likely has clinically significant depression requiring treatment 3, 4.

Studies demonstrate that the PHQ-9 performs well as a screening instrument, but a formal diagnostic process following the PHQ-9 remains imperative 5. The correlation between PHQ-9 scores and structured clinical interviews (like the SCID) is moderate to good (r = 0.61-0.71) 6, 7, supporting its utility as a screening tool but not as a standalone diagnostic instrument.

Treatment Implications

At this severity level, both pharmacologic and non-pharmacologic interventions are indicated 2. The 2023 ASCO guidelines specify that moderately severe symptomatology warrants:

• Referral to psychology and/or psychiatry for diagnosis and treatment
• Consideration of pharmacologic interventions (antidepressants chosen based on side-effect profiles, drug interactions, patient age and preference)
• Psychological interventions delivered by licensed mental health professionals (cognitive-behavioral therapy, behavioral activation, psychoeducational therapy) 1

Common Pitfalls to Avoid

1. Do not treat the PHQ-9 score as a diagnosis—it requires clinical confirmation
2. Do not skip the suicide risk assessment—this is the highest priority
3. Do not overlook medical causes of depressive symptoms that require different treatment approaches
4. Do not delay referral—moderately severe depression requires specialist evaluation, not just primary care management
5. Do not use the PHQ-9 alone to measure treatment response—while it can track symptoms, formal reassessment is needed 5